UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 29, 2009
NORTHFIELD LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
| |
|
|
|
|
Delaware
(State or Other
Jurisdiction of
Incorporation)
|
|
000-24050
(Commission File Number)
|
|
36-3378733
(IRS Employer
Identification
No.) |
1200
Business Center Drive
Mt. Prospect, Illinois 60056
(Address of Principal Executive Offices and Zip Code)
(847) 635-0066
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 3.01. Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer
of Listing..
On June 29, 2009, Northfield Laboratories Inc. (the “Company”) received notice from the Nasdaq
Stock Market that Nasdaq expects to file a Form 25 with the Securities and Exchange Commission
completing the delisting of the Company’s common stock. Trading
in the Company’s common stock
on the Nasdaq Global Market was suspended on June 11, 2009, and has not traded on Nasdaq since that
time. Delisting of the Company’s common stock will become effective ten days after the date the
Form 25 is filed with the Securities and Exchange Commission.